Funding Details
- Awarder
- Inbox
- Date Award
- February 20, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- Funding will support phase 1b/2a study of EG110A and expansion of the company's early-stage pipeline.
- Company Description
- EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
- Market
- Neuro-urology
- Location
-
Paris,
France
- Coinvestors
- Andera Partners, Bpifrance, SCI Ventures
Links